On-Demand Personalized Implant Manufacturing Infrastructure

Claim My Business
Security Type
Preferred Stock
Healthcare & Medical
Min Investment
Offering Date
November 10, 2021
Expected Close Date
April 30, 2022
Target Raise
No. Investors
Security Price
Number of Employees
Short Term Debt
Cost of Goods
Long Term Debt
Net Income

Company Description

A.D.A.M. develops an on-demand personalized implant manufacturing infrastructure with a full scope of related services, provided remotely or on site.

Key Deal Facts

Disrupt a growing market: The orthopedic implants market is expected to reach $79.5 billion in 2030.
Support innovation: A.D.A.M. leading the way in orthopaedics implant production with 3D printing methods.
Improve production times: Competitors in the implant industry have an average 2-4 weeks delivery time, while we are aiming to offer 1-3 day delivery.

Management Team / Advisory Board Bios

Denys Gurak
Denys is a former top executive of industrial conglomerates and an expert in global medical trials regulations. He has extensive experience in management and business development, having worked across the gamut of small technology ventures to industrial and government departments, and his qualifications include Master of Law, an MBA, and Master of Public Administration A member of several think tanks and NGOs, Denys holds a deep passion for world-changing technology.

Ada Bovsunovsky
Chief Operating Officer
Ada is a former venture fund analyst and has previously interned as a research analyst at a major European hedge fund. She has a BA in Economics (Boston University) and MSc in Finance (Bocconi University). As an analyst, she assisted biotech startups to build their financial models, develop investment materials and attract further financing.

Markian Silecky
General Counsel
Markian is a Corporate Counsel with over thirty years of international experience. He is a corporate attorney, co-founder of multiple multinational entities, and former Partner with Dentons. Markian specializes in general corporate law, mergers and acquisitions, and international transactions.

Andrew Pedtke MD
Chief Medical Advisor
Dr Andrew Pedtke is a physician, investor, and healthcare entrepreneur. Dr Pedtke founded LIM Innovations; a company focused on technology for those with musculoskeletal disabilities. He has secured funding through the Dept of Defense to create IoT prosthetic technology. He has subject matter expertise in additive manufacturing for orthopaedics and remote patient monitoring for performance and injury prevention. Dr. Pedtke has co-authored and presented on cutting-edge technology and value-based solutions in healthcare. He now leads a boutique corporate investing and partnership firm.
Amount Raised : $129,881
Reveal the Score by Voting
Additional ratings from other users are needed to determine a viable CrowdScore for this deal.
The "CrowdScore" for this deal is determined by user ratings and other factors using our proprietary algorithm.
The overall viability and scalability of the business concept as well as the ability to drive the concept to profitability over time.
Business Idea
The progress made thus far in demonstrating that the business has viability, a customer base or other business traction.
Business Traction
The experience of the management team in running, scaling and/or exiting a business that required similar skills to execute the business plan.
Management Team
The value of the company compared to similar companies raising money from investors.

Security Description

Preferred securities are a type of investment that generally offers some sort of preferred treatment through a dividend or preferred treatment in a liquidation.

Research Reports

No reports have been submitted

Become a Reporter